✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
DNAJC25 transcript levels are upregulated in BT-20 and ZR-75-1 cell lines and downregulated in MDA-MB-231 cell line compared to the non-tumorigenic mammary epithelial cell line (MCF 10A) (P
📌 3 Key Takeaways
🎯
Objective & Hypothesis:DNAJC25 gene is a member of the HSP40 (DNAJ) family, and it was suggested as a tumor suppressor gene in hepatocellular carcinoma.
📊
Key Findings & Data:The aim of this study was to analyze the expression, genetic/epigenetic alterations, and prognostic value of the DNAJC25 gene in breast cancer.
💡
Conclusion & Impact:DNAJC25 transcript levels are upregulated in BT-20 and ZR-75-1 cell lines and downregulated in MDA-MB-231 cell line compared to the non-tumorigenic mammary epithelial cell line (MCF 10A) (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:DNAJC25 · HSP40 · biomarker
Abstract
DNAJC25 gene is a member of the HSP40 (DNAJ) family, and it was suggested as a tumor suppressor gene in hepatocellular carcinoma. The aim of this study was to analyze the expression, genetic/epigenetic alterations, and prognostic value of the DNAJC25 gene in breast cancer. DNAJC25 transcript levels are upregulated in BT-20 and ZR-75-1 cell lines and downregulated in MDA-MB-231 cell line compared to the non-tumorigenic mammary epithelial cell line (MCF 10A) (P
🔖
Cite This Article
ACUN, T. (2021). DNAJC25 as a tumor suppressor candidate gene in breast cancer. Hacettepe Journal of Biology and Chemistry, Cilt: 49 - Sayı: 3, 305–311. https://ajindex.com/articles/255635